Thursday 8 September 2016

Eumocream 25% w / w





1. Name Of The Medicinal Product



Eumocream 25% w/w


2. Qualitative And Quantitative Composition



Glycerol 25% w/w



For excipients, see 6.1



3. Pharmaceutical Form



Cream



Smooth, white cream



4. Clinical Particulars



4.1 Therapeutic Indications



This product is indicated for the management of dry or flaky skin conditions which may also be pruritic such as eczema or dermatitis.



4.2 Posology And Method Of Administration



For topical application to the skin.



Adults, the elderly, infants, babies and children:



The cream should be applied to the affected areas as often as required.



4.3 Contraindications



Hypersensitivity to any of the ingredients.



4.4 Special Warnings And Precautions For Use



Avoid contact with the eyes, as the product may cause irritation to the epithelial cells of the cornea.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None stated



4.6 Pregnancy And Lactation



Animal studies are insufficient with respect to effects on pregnancy, foetal development, parturition or postnatal developments. The potential risk for humans is unknown.



Caution should be exercised when prescribing to pregnant women.



4.7 Effects On Ability To Drive And Use Machines



None stated



4.8 Undesirable Effects



Hypersensitivity reactions have been rarely reported; they usually consist of localised skin reactions.



4.9 Overdose



Eumocream is of low toxicity. If accidental ingestion occurs, conservative treatment only is required.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



ATC Code: D02AX



When this product is applied to the skin it acts as an emollient and humectant.



5.2 Pharmacokinetic Properties



Eumocream is for topical use only. There are no pharmacokinetic data for this product.



5.3 Preclinical Safety Data



There are no preclinical data considered relevant to clinical safety beyond data included in other sections of the SPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Glycerol monostearate 40-55



Cetostearyl alcohol



Beeswax substitute 6621 (Paraffin wax, Vegetable Stearic acid, Prime Yellow Carnauba wax)



Arlacel 165 (Glycerol Monostearate, Polyoxyethylene 100 Stearate)



Dimeticone



Chlorocresol



Sodium citrate



Citric acid monohydrate



Purified water



6.2 Incompatibilities



Not applicable



6.3 Shelf Life



36 months



6.4 Special Precautions For Storage



Do not store above 25 ÂșC. Do not freeze.



6.5 Nature And Contents Of Container



Collapsible aluminium tube internally lacquered with an epoxy coat, with a latex band and a wadless polypropylene cap.



30 g and 100 g tubes.



6.6 Special Precautions For Disposal And Other Handling



None stated



Administrative Data


7. Marketing Authorisation Holder



Beecham Group Plc



980 Great West Road



Brentford



Middlesex



TW8 9GS



Trading as: GlaxoSmithKline Consumer Healthcare, Brentford, TW8 9GS, U.K.



8. Marketing Authorisation Number(S)



PL 00079/0644



9. Date Of First Authorisation/Renewal Of The Authorisation



03/04/2007



10. Date Of Revision Of The Text



12/03/2009




No comments:

Post a Comment